SEC Form 4 · accession 0001225208-16-033206
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie L. Gerberding
Officer — EVP Strat Comm, Gl Pub Policy
Period of report
May 10, 2016
Accepted (ET)
May 12, 2016 · 11:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 38,655 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $54.68 | May 10, 2016 | A | 54,329 | A | May 10, 2017 | May 9, 2026 | Common Stock | 54,329 | 54,329 | D |
Explanation of responses
- F1Holdings include shares acquired in dividend reinvestment transactions.
- F2The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.